Department of Orthopaedic Surgery, Harbor-UCLA Medical Center, Torrance, CA, USA.
Clin Orthop Relat Res. 2013 Nov;471(11):3475-81. doi: 10.1007/s11999-013-3014-7.
An emphasis on "value" over volume in health care is driving new healthcare measurement, delivery, and payment models. Orthopaedic surgery is a major contributor to healthcare spending and, as such, is the focus of many of these new models. WHERE ARE WE NOW?: An evaluation of "value" in orthopaedics requires information that has not traditionally been collected as part of routine clinical practice. If value is defined as patient outcomes in relation to healthcare costs, we need to collect information about both. In orthopaedics, patient-reported functional status is not routinely measured, and a poor understanding of the costs associated with the provision of musculoskeletal care limits our ability to quantify and report on financial measures. WHERE DO WE NEED TO GO?: To improve the value of musculoskeletal care, we need to focus on both improving outcomes and controlling costs. To improve outcomes, orthopaedists must agree on a set of outcome measures for appropriate care and advocate for their collection through the use of registries. Orthopaedic registries in several countries provide best practices for this information collection and sharing. In the United States, we should make comparable investments in registries to measure patient-reported outcomes. To address escalating costs, we need to improve the accuracy of cost data by applying modern cost accounting processes. HOW DO WE GET THERE?: Orthopaedists should take a leadership position in the promotion and implementation of value-based health care by advocating for the use of registries to measure risk-adjusted patient specific outcomes, negotiating with payors for value-based payment incentives and applying modern cost accounting processes to control costs rather than waiting for public and private payors to define components of the value equation that will affect how orthopaedic surgeons are evaluated and compensated in the future.
医疗保健领域对“价值”而非“数量”的重视,推动了新的医疗保健衡量、交付和支付模式。骨科手术是医疗保健支出的主要贡献者,因此也是许多新模式的重点。我们现在在哪里?:评估骨科的“价值”需要的信息传统上不作为常规临床实践的一部分收集。如果价值被定义为患者的结果与医疗成本的关系,我们需要收集关于两者的信息。在骨科,患者报告的功能状态没有被常规测量,并且对与提供肌肉骨骼护理相关的成本的理解有限,这限制了我们量化和报告财务措施的能力。我们需要去哪里:为了提高肌肉骨骼护理的价值,我们需要关注改善结果和控制成本。为了改善结果,骨科医生必须就适当护理的一整套结果衡量标准达成一致,并通过使用登记处来倡导收集这些标准。一些国家的骨科登记处为这种信息收集和共享提供了最佳实践。在美国,我们应该在登记处进行类似的投资,以衡量患者报告的结果。为了解决成本不断上升的问题,我们需要通过应用现代成本核算流程来提高成本数据的准确性。我们如何到达那里:骨科医生应该通过倡导使用登记处来衡量风险调整后的患者特定结果,与支付方协商基于价值的支付激励措施,并应用现代成本核算流程来控制成本,而不是等待公共和私人支付方来定义影响未来骨科医生评估和补偿的价值方程的组成部分,从而在推广和实施基于价值的医疗保健方面发挥领导作用。